메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

OMRON Healthcare Singapore partners with bolttech and QBE to launch innovative embedded health solution

The comprehensive subscription programme offers OMRON customers in Singapore access to personalised health protection and insights SINGAPORE, July 22, 2025 -- Global insurtech bolttech and OMRON Healthcare Singapore, a global leader in innovative medical equipment for health monitoring and therapy, today announced the launch of their Premium Care subscription plan in Singapore. This three-in-one premium subscription programme offers registered OMRON connect members personalised health insights, protection and exclusive services tailored to OMRON device owners. Underwritten by
- 김갑성 기자
- 2025-07-22 09:30
CPHI & PMEC 선전 2025: 아시아와 그레이터 베이 지역에 새로운 기회 창출

[ 메디채널 김갑성 기자 ] 상하이 2025년 7월 22일 -- CPHI & PMEC 차이나 2025(CPHI & PMEC China 2025) 가 6월에 막을 내리며 총 109056명의 역대 최다 참관객을 기록, 중국 제약 산업의 강력한 수요를 다시 한번 입증했다. 이러한 성공을 바탕으로 CPHI & PMEC 선전 2025(CPHI & PMEC Shenzhen 2025)가 2025년 9월 1일부터 3일까지 선전 컨벤션 및 전시 센터(Shenzhen Convention & Exhibition Center, SZCEC)에서 개최된다. 이번 행사는 중국 남부의 주요 제약 시장에 대한 접근 수요 증가에 대응하기 위해 마련됐다. 광둥-홍콩-마카오 그레이터 베이 지역(Guangdong-Hong Kong-Macau Greater Bay Area)의 핵심 관문인 선전은 제약 혁신의 중심지로 부상하고 있다. 이 지역의 헬스 산업 GDP는 2028년까지 2조 위안을 넘어서고 2030년에는 2조 5천억~3조 위안에 이를 것으로 전망되며, 이로 인해 성장과 협업 기회가 전례 없이 확대될 것으로 예상
- 김갑성 기자
- 2025-07-22 08:26
2025 Inaugural Global Chest Wall Surgery Conference Concludes Successfully: Uniting Expertise, Driving Innovation

GUANGZHOU, China, July 21, 2025 -- The inaugural Global Chest Wall Surgery Conference concluded successfully in Guangzhou on July 19, uniting leading medical experts worldwide to share cutting-edge surgical innovations and clinical insights in chest wall surgery. The conference featured a series of high-level academic lectures focusing on the latest developments, advanced techniques, emerging trends, and key issues in chest wall surgery. 9 distinguished medical experts from the United States, India, Japan, Malaysia, Armenia, Thailand, and China delivered keynote speeches, attracting ne
- 김갑성 기자
- 2025-07-21 22:33
ICWS Successfully Concludes 2nd Global Program on Cutting-edge Chest Wall Surgery Techniques

GUANGZHOU, China, July 21, 2025 -- The 2nd "Latest Chest Wall Surgery Technique Global Training Program", hosted by the Institute of Chest Wall Surgery (ICWS) of Guangdong Second Provincial General Hospital, was successfully held from July 16 to 18, 2025. The program brought together 10 thoracic surgeons from the United States, Romania, India, Armenia, Pakistan, Malaysia, Mexico, and other countries. Participants engaged in comprehensive training on the latest diagnostic methods and surgical techniques in chest wall surgery. A highlight was the innovative surgical appr
- 김갑성 기자
- 2025-07-21 22:32
Minaris Advanced Therapies Welcomes Orla Cloak as Chief Executive Officer

PHILADELPHIA, July 21, 2025 -- Minaris Advanced Therapies is pleased to announce the appointment of Dr. Orla Cloak as Chief Executive Officer. Dr. Cloak is a seasoned executive with over 20 years of commercial leadership experience in the Pharma and Life Science industries. She brings with her a proven track record of driving innovation, operational excellence, sustainable business growth and strategic leadership. Prior to joining Minaris Advanced Therapies, Orla held several leadership positions at Lonza over a 17-year period, most recently serving as Senior Vice President an
- 김갑성 기자
- 2025-07-21 21:00
Bloomage Achieves FDA GMP Audit with Zero-Deficiency, Reinforcing Global Trust

PARSIPPANY, N.J., July 21, 2025 -- Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has announced it successfully passed the U.S. Food and Drug Administration (FDA)'s on-site GMP audit with a "No Action Indicated" (NAI) result. This is the best possible result, confirming complete compliance with no objectionable conditions ("zero-deficiency"). The FDA's issuance of a Current Good Manufacturing Practice (CGMP) compliance notification and Establishment Inspection Report (EIR) formally recognizes Bloomage's pharmaceutical quality
- 김갑성 기자
- 2025-07-21 21:00
BON Announces $22 Million Distribution Agreement for Weight Loss Products with Beijing Huahai Keyuan Technology Co., Ltd

XI'AN, China, July 21, 2025 -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural health and personal care industries, today announced it has entered into a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan"). The term of the agreement is 36 months with a total contract value of US$22 million. Pursuant to the agreement, Huahai Keyuan will sell and distribute Bon's natural weight loss product line across China and Southeast Asi
- 황정호 기자
- 2025-07-21 21:00
미나리스 어드밴스드 테라피스, 오를라 클로크 신임 CEO 임명

필라델피아, 2025년 7월 21일 -- 미나리스 어드밴스트 테라피스(Minaris Advanced Therapies)가 오를라 클로크 박사(Dr. Orla Cloak)를 신임 최고경영자(CEO)로 임명했다고 발표했다. 클로크 박사는 제약 및 생명과학 업계에서 20년 이상 상업 분야 리더십 경험을 쌓은 경영 전문가로, 혁신, 운영 우수성, 지속 가능한 비즈니스 성장, 전략적 리더십 분야에서 입증된 실적을 보유하고 있다. 미나리스 어드밴스트 테라피스 합류 전에는 론자(Lonza)에서 17년간 다양한 리더십 직책을 역임했으며, 가장 최근에는 론자 바이오사이언스(Lonza Bioscience) 사업부 수석 부사장 겸 책임자를 역임했다. 클로크 박사는 유니버시티 칼리지 더블린(UCD)에서 이학 학사 학위를, 얼스터대학교에서 미생물학 박사 학위를 취득했다. 이언 베어드(Iain Baird) 미나리스 어드밴스드 테라피스 이사회 의장은 "이사회는 클로크 박사의 합류를 진심으로 환영한다"며 "클로크 박사의 리더십은 고객이 혁신적인 치료법을 성공적으로 상용화할 수 있도록 지원한다는 당사의 사명을 실현하는 데
- 김갑성 기자
- 2025-07-21 21:00
Cenra Healthcare and Dr. Reddy's Strengthen Strategic Partnership to Expand Access to Medicines in Taiwan

TAIPEI, July 21, 2025 -- Cenra Healthcare, the sales and marketing arm of Cenra Inc. (TWSE: 3716), today announced the deepening of its long-standing collaboration with the global pharmaceutical company Dr. Reddy's Laboratories (Taiwan) Ltd (Dr. Reddy's). Since the partnership began in 2020, the two companies have worked closely to introduce a diverse range of high-quality generic drugs and innovative formulations to patients in Taiwan, with a shared commitment to broadening access to affordable and clinically valuable treatments. "We are proud to strengthen our collaborat
- 김갑성 기자
- 2025-07-21 19:35
CPHI & PMEC Shenzhen 2025: Unlocking New Opportunities in Asia and the Greater Bay Area

SHANGHAI, July 21, 2025 -- CPHI & PMEC China 2025 concluded in June with a record-breaking 109,056 attendees, underscoring strong demand within China's thriving pharma industry. Building on this success, CPHI & PMEC Shenzhen 2025 will take place from 1–3 September 2025 at Shenzhen Convention & Exhibition Center (SZCEC), addressing the growing demand for access to South China's key pharma markets. As a key gateway to the Guangdong-Hong Kong-Macau Greater Bay Area, Shenzhen is positioned to drive pharma innovation. The region's health industry GDP is projected
- 김갑성 기자
- 2025-07-21 14:31

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2025-09-01_MON

2025-08-31_SUN

2025-08-30_SAT

Global Trade Review Announces GTR Asia 2025 in Singapore - the premier platform for the trade community in the Asia Pacific region - hits over 1,500 registration for September 2-3 23:39

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 01일 09시 00분